Overview

Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness

Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether rifampin and/or azithromycin are effective in the treatment of river blindness (onchocerciasis).
Phase:
Phase 2
Details
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborators:
Universidad del Valle, Guatemala
University of Alabama at Birmingham
Treatments:
Azithromycin
Rifampin